Shares of ResMed Inc. RMD inched 0.81% higher to $244.94 Friday, on what proved to be an all-around mixed trading session for ...

Eli Lilly (NYSE:LLY) is taking the unusual step of asking people who took compounded versions of their drug tirzepatide, ...

Global Home Respiratory Therapy Market is valued at approximately USD 8.55 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 6.72% over the forecast period 2024-2032.

In a high-flying market, finding ASX value shares with a balance of quality fundamentals and growth is key, Let's dive in.

ResMed faces a 3% drop in share price after concerns over Eli Lilly’s Ozempic, which could impact the demand for CPAP ...